Cases & Deals

Share

Cibus combines with Calyxt

January 2023

Clients Cibus Global, LLC

Jones Day is advising Cibus Global, LLC (“Cibus”), a San Diego based leader in precision gene editing in agriculture, in connection with a proposed all-stock merger with Calyxt, Inc. (NASDAQ: CLXT), under which Cibus and Calyxt will create an industry-leading company that combines two pioneers in agriculture-based gene editing and establishes one of the world’s most sophisticated facilities for trait development and plant breeding. Under the terms of the merger agreement, Calyxt will issue shares of its common stock to Cibus shareholders in an exchange ratio such that upon completion of the merger, Cibus shareholders will own approximately 95% of the combined company and the Cibus leadership team will lead the new organization. Upon closing, the combined company will be renamed Cibus, Inc. and will trade on the Nasdaq Capital Market.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.